Mirati Therapeutics Inc. (MRTX) Loss -22.75% YTD: Chances Are, Buyers Will Win the Tug-of-War
Mirati Therapeutics Inc. (NASDAQ:MRTX) Relative Strength Index (RSI) is 62.64, with weekly volatility at 4.34% and ATR at 7.15. The MRTX stock’s 52-week price range